mascc2017 > Posters

Login

Antiemetics

Previous Next

Joerg Schilling
QUALITY OF LIFE AND EFFICACY OF NEPA AS CINV PROPHYLAXIS IN HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY – INTERIM RESULTS OF A GERMAN NON-INTERVENTIONAL STUDY
Download
doreen pon
THE FREQUENCY AND PATTERNS OF LORAZEPAM PRESCRIBING AND ADMINISTRATION IN HOSPITALIZED ONCOLOGY PATIENTS
Download
Ayesha Afzal
ONDANSETRON A NOVAL ANTI EMETIC
Edric Paw Cho Sing
SAFETY OF DEXAMETHASONE FOR NAUSEA AND VOMITING PROPHYLAXIS IN CHILDREN RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Florian Scotte
ANTICIPATIVE MONITORING IMPROVES CHEMOTHERAPY INDUCED NAUSEA
Download
Jennifer Vanden Burgt
CISPLATIN DOSE-DEPENDENT EFFECT ON NAUSEA CONTROL: SUBSET ANALYSIS FROM A PHASE 3 TRIAL OF NEPA VERSUS APREPITANT/GRANISETRON
Download
Keith Cox
ONLINE LEARNING INITIATIVE TO ADDRESS THE ONGOING CLINICAL CHALLENGES OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV)
Download
Kouichi Yamamoto
EFFECT OF ANTI-EMETIC DRUGS ON CHEMOTHERAPEUTIC AGENTS-INDUCED GRIMACE EXPRESSION IN RATS
Shiru (Lucy) Liu
GUIDELINE ADHERENCE MATTERS: RATES AND CONSEQUENCES OF NON-ADHERENCE TO ANTIEMETIC PRACTICE GUIDELINES
Download
Masakazu Abe
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY EVALUATING OLANZAPINE 5MG COMBINED WITH STANDARD ANTIEMETIC THERAPY FOR THE PREVENTION OF CINV IN PATIENTS RECEIVING CISPLATIN-BASED CHEMOTHERAPY
Download
Meinolf Karthaus
PHASE 3 EFFICACY AND SAFETY STUDY OF PALONOSETRON IV INFUSION VERSUS IV BOLUS FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) PROPHYLAXIS FOLLOWING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC)
Download
Koji OBA
SYSTEMATIC REVIEW AND INDIVIDUAL PATIENT DATA META-ANALYSIS OF PALONOSETRON TRIALS FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: DEXAMETHASONE FOR 3 DAYS VERSUS DEXAMETHASONE FOR 1 DAY ALONE
Download
Priya Patel
APREPITANT AND FOSAPREPITANT DRUG INTERACTIONS: A SYSTEMATIC REVIEW
Download
Ralph V. Boccia
A RETROSPECTIVE CHART REVIEW OF HYPERSENSITIVITY AND INFUSION-SITE ADVERSE EVENTS (ISAES) ASSOCIATED WITH FOSAPREPITANT IV IN PATIENTS RECEIVING ANTHRACYCLINE AND CYCLOPHOSPHAMIDE (AC)-BASED CHEMOTHERAPY
Download
Leonard Chiu
EFFICACY OF OLANZAPINE FOR THE PROPHYLAXIS AND RESCUE OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV): A SYSTEMATIC REVIEW AND META-ANALYSIS
Download
Leonard Chiu
OLANZAPINE FOR THE PROPHYLAXIS AND RESCUE OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV): A RETROSPECTIVE STUDY
Download
Ronald Chow
EFFICACY AND SAFETY OF OLANZAPINE FOR THE PROPHYLAXIS OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) AS REPORTED IN PHASE I AND II STUDIES: A SYSTEMATIC REVIEW
Download
Ronald Chow
THE COMBINATION OF NK1 RECEPTOR ANTAGONIST, PALONOSETRON, AND DEXAMETHASONE FOR THE PROPHYLAXIS OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING: A SYSTEMATIC REVIEW AND META-ANALYSIS
Download
Rudolph Navari
ROLAPITANT FOR THE PREVENTION OF NAUSEA IN PATIENTS RECEIVING CISPLATIN- OR CARBOPLATIN-BASED CHEMOTHERAPY: ALTERNATIVE METHODS FOR EVALUATING NAUSEA
Download
Russell Knoth
EXAMINING RATES OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN LUNG CANCER TREATED WITH ANTIEMETIC PROPHYLAXIS RECOMMENDED BY THE MASCC ANTIEMESIS GUIDELINES
Russell Knoth
COMPARING RATES OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN PATIENTS WITH BREAST CANCER RECEIVING AC CHEMOTHERAPY TREATED WITH PALONOSETRON VS. ANOTHER 5HT3RA
Russell Knoth
COMPARING RATES OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN PATIENTS WITH LUNG CANCER RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY TREATED WITH PALONOSETRON VS. ANOTHER 5HT3RA
Suthan Chanthawong
COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE-CONTAINING ANTIEMETIC THERAPY FOR MANAGING HIGHLY EMETOGENIC CHEMOTHERAPY IN SOUTH EAST ASIA: A MULTINATIONAL STUDY.
Download